GLAXO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - GlaxoSmithKline Pakistan Ltd

Watchlist Manager

Watchlist

Price: 350.87 PKR 0.11% Market Closed

Market Cap: Rs111.7B

G	GlaxoSmithKline Pakistan Ltd KAR:GLAXO	PK
	Elicera Therapeutics AB F:8E8	SE
	Ibio Inc F:0JV	US
B	Basler AG DUS:BSL	DE
E	Emergent BioSolutions Inc XBER:ER4	US
A	ATOSS Software SE XHAN:AOF	DE
	Alligator Bioscience AB F:7AL	SE
M	Microchip Technology Inc XHAN:MCP	US
S	SanDisk Corp XHAN:BW9	US
	Immunovant Inc NASDAQ:IMVT	US
	Absci Corp NASDAQ:ABSI	US
	Knowit AB (publ) F:KOW	SE
	Capcom Co Ltd OTC:CCOEY	JP
G	Gilat Satellite Networks Ltd F:GSA	IL
N	National Fuel Gas Co F:NFG	US
	Agora Inc NASDAQ:API	CN
F	Fresenius Medical Care AG XHAN:FME	DE
	Cerillion PLC F:1VW	UK

Profitability Summary

GlaxoSmithKline Pakistan Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

38%

Sustainable 3Y Average Gross Margin

23%

Gross Margin is Increasing

11% > 38%

Healthy Operating Margin

25%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

7% > 25%

Healthy Net Margin

16%

Low 3Y Average Net Margin

Net Margin is Increasing

3% > 16%

Exceptional Free Cash Flow Margin

12%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-12% > 12%

Exceptional ROE

32%

Positive 3Y Average ROE

Positive 3Y Average ROIC

18%

ROIC is Increasing

5% > 32%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.